Magellan Rx Pharmacists Explore the Payer Perspective on Oncology Biosimilars
April 18th 2021Rebecca Borgert, PharmD, BCOP, and Jim Rebello, PharmD, from Magellan Rx Management talk about how market trends, payer formulary decisions, and international successes are shaping today's biosimilars industry.